Related Experiment Video

Updated: Dec 22, 2025

Determination of the Relative Cell Surface and Total Expression of Recombinant Ion Channels Using Flow Cytometry
11:32

Determination of the Relative Cell Surface and Total Expression of Recombinant Ion Channels Using Flow Cytometry

Published on: September 28, 2016

13.7K

Ischemic Heart Disease and Heart Failure: Role of Coronary Ion Channels

Paolo Severino1, Andrea D'Amato1, Mariateresa Pucci1

  • 1Department of Clinical, Internal, Anesthesiology and Cardiovascular Sciences, Sapienza University of Rome, Viale del Policlinico, 155-00161 Rome, Italy.

International Journal of Molecular Sciences
|May 6, 2020
PubMed

Insights

Ion channels are crucial in heart failure, linking coronary microvascular dysfunction to ischemic heart disease. Understanding these channels can reveal new pathways for treating heart failure.

Area of Science:

  • Cardiology
  • Physiology
  • Molecular Biology

Background:

  • Heart failure is a major cause of death and hospitalization.
  • Ischemic heart disease, often due to coronary artery disease, leads to heart failure by reducing blood flow.
  • The role of coronary microcirculation in heart failure pathophysiology is increasingly recognized.

Purpose of the Study:

  • To explore the role of ion channels in the pathophysiology of ischemic heart disease and heart failure.
  • To investigate how coronary microvascular dysfunction, influenced by ion channels, contributes to myocardial damage.
  • To establish ion channels as a potential link between microvascular dysfunction and heart failure.

Main Methods:

  • Review of existing literature on coronary microcirculation and ion channel function.
  • Analysis of pathophysiological mechanisms linking microvascular dysfunction to myocardial ischemia.
  • Exploration of the role of ion channels in regulating coronary blood flow and myocardial metabolism.

Main Results:

  • Coronary microvascular dysfunction impairs the heart's ability to meet metabolic demands, causing hypoxia and tissue death.
  • This dysfunction can lead to myocardial damage and loss of function, independent of epicardial plaque presence.
  • Imbalances in ion channel function are implicated in the dysregulation of coronary blood flow.

Conclusions:

  • Ion channels play a critical role in the complex pathophysiology of ischemic heart disease and heart failure.
  • Coronary microvascular dysfunction, mediated by ion channels, is a significant factor in heart failure development.
  • Targeting ion channels may offer novel therapeutic strategies for heart failure associated with ischemic heart disease.

Keywords:
coronary artery diseasecoronary microvascular dysfunctionheart failureion channelischemic heart diseasemicrocirculation

More Related Videos

Improved Rodent Model of Myocardial Ischemia and Reperfusion Injury07:23

Improved Rodent Model of Myocardial Ischemia and Reperfusion Injury

Published on: March 7, 2022

6.9K
Isolation and Functional Characterization of Human Ventricular Cardiomyocytes from Fresh Surgical Samples14:39

Isolation and Functional Characterization of Human Ventricular Cardiomyocytes from Fresh Surgical Samples

Published on: April 21, 2014

17.7K

Related Concept Videos

Antianginal Drugs: Calcium Channel Blockers and Ranolazine01:25

Antianginal Drugs: Calcium Channel Blockers and Ranolazine

Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
1.2K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
289
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
174
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
2.6K
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
1.1K
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
585